• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Catalog Number 08D06-77
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/27/2022
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A final report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.  phone complete entry: (b)(6).
 
Event Description
The customer observed a false non-reactive architect syphilis tp result for a 63 year old male patient.The following data was provided (<1.00 s/co is nonreactive, >/=1.00 s/co is reactive): sample id: (b)(6), initial result = 0.08 s/co, repeat result = 0.09 s/co, rapid plasma reagin (rpr) = 1:16 (positive).No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false nonreactive architect syphilis results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history review, in house testing of a retained reagent kit, and return sample testing was completed.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot 37093be01 and the complaint issue.In-house testing of a retained reagent kit of the complaint lot was performed.All controls met specifications and no false non-reactive results were obtained, indicating that the lot generates the expected results.Labeling was reviewed and sufficiently addresses the customer's issue.The returned specimen sample id (b)(6) was tested with the following results: architect syphilis tp: 0.09 s/co (non-reactive), recomline treponema igm: negative, recomline treponema igg: negative.In-house testing of the return sample was performed with architect syphilis tp lot 41106be01, due to the complaint lot 37093be01 not being available for testing.No discrepant results were generated.Based on the investigation, no systemic issue or deficiency with the architect syphilis reagent lot 37093be01 was identified.
 
Event Description
Additional information was provided but the customer stating that after sending the sample for confirmatory testing, the result was negative, which was consistent with the abbott platform result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT SYPHILIS TP REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15742845
MDR Text Key307473339
Report Number3002809144-2022-00386
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K153730
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/28/2023
Device Catalogue Number08D06-77
Device Lot Number37093BE01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/27/2022
Initial Date FDA Received11/07/2022
Supplement Dates Manufacturer Received11/28/2022
Supplement Dates FDA Received12/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/11/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6) ; ARC I2000SR INST, 03M74-02, (B)(6)
Patient Age63 YR
Patient SexMale
-
-